Tango Therapeutics, Inc., a clinical─stage biotechnology company committed to discovering the next generation of precision cancer medicines,...
Vous n'êtes pas connecté
- THEWEST.COM.AU - Business - 10/07/2024 07:01
Radiopharm unveils landmark human lung cancer trial
Radiopharm Theranostics has kicked off the first phase of clinical trials testing its “RAD 204” treatment aimed at beating the most common type of lung cancer after dosing its first patient in New South Wales.
Articles similaires
Tyra Biosciences begins patient dosing in phase 2 study of TYRA─300 in low─grade intermediate risk non─muscle invasive bladder cancer
pharmabiz.com - 01/Jul 10:47
Tyra Biosciences, Inc., a clinical─stage biotechnology company focused on developing next─generation precision medicines that target large...
Evolution Of China’s Biotech Industry: Crouching Tiger, Hidden Dragon – Analysis
eurasiareview.com - 26/Jun 00:28
By Lakshmy Ramakrishnan Biotechnology is a critical emerging technology holding significant potential in addressing various challenges,...
Amgen Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-line Gastric Cancer
drugs.com - 30/Jun 03:06
THOUSAND OAKS, Calif., June 30, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Phase 3 FORTITUDE-101 clinical trial evaluating...
Inmagene enrolls first patient in ADAPTIVE phase 2b clinical trial of IMG─007
pharmabiz.com - 04/Jul 10:12
Inmagene Biopharmaceuticals (Inmagene), a clinical─stage biotechnology company dedicated to developing innovative and differentiated therapies for...
Aspire Biopharma enrolls last patient in phase 1 trial of its oral transmucosal fast─acting high─dose aspirin formulation
pharmabiz.com - 26/Jun 14:53
Aspire Biopharma Holdings, Inc, developer of a multi─faceted patent─pending drug delivery technology, announced the last patient was dosed in its...
Onco-Innovations reveals new study on global applicability of lung cancer clinical trials
themarketherald.ca - 02/Jul 10:45
This content has been prepared in collaboration with Onco-Innovations Ltd., a third-party…
Breakthrough cancer treatment being made in Victoria
aumanufacturing.com.au - 03/Jul 02:37
Victoria has opened Australia’s first facility accredited to manufacture a targeted cancer treatment that significantly improves patient survival...
Skin Cancer: The Most Common Cancer in America—Here Are the Warning Signs to Watch For
wn.com - 29/Jun 12:10
Skin cancer is the most common type of cancer in the United States, and its...
Les derniers communiqués
-
Aucun élément